Skip to main content
. 2013 May 30;4:47. doi: 10.3389/fpsyt.2013.00047

Figure 2.

Figure 2

A schematic illustration of putative pathological processes in schizophrenia – emphasizing the interactions among neuromodulatory mechanisms. These mechanisms include: (i) decreased prefrontal NMDA-R function that may reduce the stimulation of VTA-DA neurons that project back to prefrontal D1Rs (decreasing cortical precision), and disinhibition of VTA-DA neurons that project to the striatum; (ii) increased dopamine release from SNc-DA neurons disinhibits the indirect pathway (by direct inhibition of striatal GABA neurons, inhibition of striatal cholinergic interneurons, and reduction of glutamate release in corticostriatal neurons); (iii) reduced NMDA-R stimulation of cortical PVBC’s reduces activity of these GABAergic interneurons, impairing coordination of cortical oscillatory activity; and (iv) increased hippocampal drive to the VTA, leading to hyperdopaminergia in the VStr. Significant omissions (for clarity) include: the GP, SNr, STN, and Thal, most connections of the VStr including its direct and indirect pathways and excitatory connections from the VTA (via D1Rs), and circuitry within the VStr, two more inhibitory connections in the indirect pathway and both somatic and axonal dopamine neuron D2 autoreceptors in SNc. As in other figures, descending projections are in black and ascending projections in red. Abbreviations: PPT, pedunculopontine tegmental nucleus; VTA, ventral tegmental area; VStr, ventral striatum; DStr, dorsal striatum; SNc/r, substantia nigra pars compacta/reticulata; GP, globus pallidus; Thal, thalamus; STN, subthalamic nucleus; PVBC, parvalbumin-positive basket cell. Stephan et al. (2009), Morrison (2012), Carlsson et al. (1999), Lisman et al. (2008), Simpson et al. (2010).

HHS Vulnerability Disclosure